Frontlight ResearchEarly access
Trial site
City of Hope Mission Hills
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Metastatic breast cancer4 trials
- Triple-negative breast cancer2 trials
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Liver and biliary tract cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Thymoma and thymic carcinoma1 trial
- Phase
- Phase 36 trials
- Phase 24 trials
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- SWOG Cancer Research Network5 trials
- City of Hope Medical Center3 trials
- National Cancer Institute (NCI)3 trials
- Alliance for Clinical Trials in Oncology1 trial
- ECOG-ACRIN Cancer Research Group1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026